↓ Skip to main content

Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B

Overview of attention for article published in this source, April 2003
Altmetric Badge

Mentioned by

blogs
1 blog
policy
1 policy source

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
33 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B
Published by
John Wiley & Sons, Ltd, April 2003
DOI 10.1002/14651858.cd002799
Pubmed ID
Authors

Wun, Yuk Tsan, Dickinson, James A

Abstract

Chronic hepatitis B infection may cause liver cancer (hepatocellular carcinoma (HCC)). Alpha-fetoprotein (AFP) and liver ultrasonography (US) are used to screen these patients for HCC. It is uncertain whether screening is worthwhile.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Lebanon 1 3%
Germany 1 3%
Unknown 30 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 18%
Researcher 6 18%
Other 3 9%
Lecturer > Senior Lecturer 2 6%
Student > Master 2 6%
Other 4 12%
Unknown 10 30%
Readers by discipline Count As %
Medicine and Dentistry 14 42%
Nursing and Health Professions 3 9%
Engineering 2 6%
Sports and Recreations 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 2 6%
Unknown 10 30%